Announcements
Open Access
Review
Contemporary Biomarker Strategies for Patients with Chest Pain
Show Less
1
Department of Emergency Medicine, Baylor College of Medicine, 1 Baylor Plaza, Houston, TX 77030, USA
*Correspondence: Sboonemd@gmail.com (Stephen Boone)
Academic Editor: Carlo Briguori
Academic Editor: Carlo Briguori
Rev. Cardiovasc. Med. 2022, 23(5), 157;
https://doi.org/10.31083/j.rcm2305157
Submitted: 21 January 2022 | Revised: 10 March 2022 | Accepted: 17 March 2022 | Published: 27 April 2022
(This article belongs to the Special Issue Evaluation of Chest Pain in the Emergency Department)
Copyright: © 2022 The Author(s). Published by IMR Press.
This is an open access article under the CC BY 4.0 license.
Abstract
This review focuses on the strengths and limitations of conventional and high-sensitivity troponin in the evaluation of patients with suspected acute coronary syndromes. High-sensitivity troponin (hsTn) assays represent a significant innovation over prior generation troponin assays. Owing to superior analytical precision, hsTn permits more rapid “rule-in” and “rule-out” of myocardial infarction. Furthermore, hsTn assays, in properly implemented clinical pathways, permit a reduction in the portion of patients requiring extended observation and testing.
Keywords
troponin
high sensitivity troponin
chest pain
acute coronary syndrome
biomarkers
Figures
Fig. 1.